Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
From Courtroom Daily · · 4 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
The United States Food and Drug Administration has issued a formal directive to manufacturers of popular GLP-1 weight-loss and diabetes medications. These companies are now required to update their product labels to include warnings about a rare, potentially serious eye condition that can lead to sudden and permanent vision loss.